Exendin-4 attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression

Cardiology Journal

Volumn 20, Issue 6, 2013, Pages 600-604

  Hu, Gangying ^a   Zhang, Yijie ^a   Jiang, Hong ^a   Hu, Xiaorong ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI POLYTECHNIC UNIVERSITY   (China)

Author keywords

Exendin 4; High mobility group box 1 protein; Myocardial ischemia; Reperfusion

Indexed keywords

ANTIDIABETIC AGENT; CREATINE KINASE; EXENDIN 4; EXENDIN 9 39; HEPARIN; HIGH MOBILITY GROUP B1 PROTEIN; LACTATE DEHYDROGENASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; IMMUNOBLOTTING; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANIMALS; CREATINE KINASE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HMGB1 PROTEIN; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PEPTIDE FRAGMENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCAGON; SUPEROXIDE DISMUTASE; TIME FACTORS; VENOMS;

EID: 84890359067     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.2013.0159     Document Type: Article

References (22)

1. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 2002; 418: 191-195.
2. Bell CW, Jiang W, Reich CF et al. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol, 2006; 291: C1318-C1325.
3. Andrassy M, Volz HC, Igwe JC et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation, 2008; 117: 3216-3226.
4. Hu X, Jiang H, Bai Q et al. Increased serum HMGB1 is related to the severity of coronary artery stenosis. Clin Chim Acta, 2009; 406: 139-142.
5. Andrassy M, Volz HC, Riedle N et al. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med, 2011; 270: 245-253.
6. Zhao D, Wang Y, Xu Y. Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation. Int J Cardiol, 2012; 158: 471-472.
7. Frangoginis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res, 2002; 53: 31-47.
8. Hu X, Fu W, Jiang H. HMGB1: A potential therapeutic target for myocardial ischemia and reperfusion injury. Int J Cardiol, 2012; 155: 489-489.
9. Kieffer TJ, and Habener JF. The glucagon-like peptides. Endocr Rev, 1999; 20: 876-913.
10. Bose AK, Mocanu MM, Carr RD et al. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes, 2005; 54: 146-151.
11. Sokos GG, Nikolaidis LA, Mankad S et al. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail, 2006; 12: 694-699.
12. Sonne DP, Engstrom T, Treiman M. Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart. Regul Pept, 2008; 146: 243-249.
13. Okerson T, Chilton RJ. The Cardiovascular effects of GLP-1 receptor agonists. Cardiovasc Ther, 2012; 30: e146-e155.
14. Cai Y, Hu X, Yi B et al. Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression. Mol Biol Rep, 2012; 39: 10705-10711.
15. Wu L, Olverling A, Huang Z et al. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats. Clin Sci, 2012; 122: 375-384.
16. Zhang K, Wu Y, Zhao L et al. Exendin-4 attenuates ischemia--induced ventricular arrhythmias in rats. Cardiol J, 2013; 20: 29-33.
17. Hu X, Cui B, Zhou X et al. Ethyl pyruvate reduces myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Mol Biol Rep, 2012; 19: 227-231.
18. Timmers L, Henriques JPS, de Kleijn DPV et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol, 2009; 53: 501-510.
19. Hu X, Zhou X, He B et al. Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur J Pharmacol, 2010; 638: 84-89.
20. Gottlieb RA, Engler RL. Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci, 1999; 68: 412-426.
21. Tang D, Shi Y, Kang R et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol, 2007; 81: 741-747.
22. Tsung A, Klune JR, Zhang X et al. HMGB1 release induced by liver ischemia involves toll-like receptor 4-depedent reactive oxygen species production and calcium-mediated signaling. J Exp Med, 2007; 204: 2913-2923.